Mankind Pharma in talks with PE for consortium bid of Bharat Serums: Report

Mankind Pharma is in talks with PE companies to acquire Bharat Serums and Vaccines. Owner Advent International aims to sell BSV for over $2 billion, with the final transaction expected to be between $1.5-1.8 billion.

Livemint
First Published13 Jun 2024, 02:20 PM IST
Mankind is the fourth largest drug manufacturer in India by sales.
Mankind is the fourth largest drug manufacturer in India by sales.(Reuters / Dado Ruvic)

Mankind Pharma is in talks with many private equity (PE) companies to form a joint bid to acquire Bharat Serums and Vaccines (BSV) in a consortium, the Hindu BusinessLine reported, citing sources.

Also Read | HCC gained 31% in June so far, up 162% in last one year; is it a good time to buy the stock?

Bain Capital, Blackstone, Carlyle, and KKR expressed interest in BSV after its current owner, Advent International, put it up for sale. While Mankind is in talks with these firms, the HBL report added that not all are interested in forming a consortium. For example, Blackstone has submitted two individual non-binding bids and has not expressed interest in the collaboration.

Mankind and Blackstone did not respond to queries, the report added. Livemint could not independently verify the report.

Also Read | Modi 3.0: First GST Council meeting to be held on June 22

Potential Sale Price

Advent International wants to sell BSV for over $2 billion. However, sources told the paper that the final transaction may range between $1.5 -1.8 billion.

Sources told the paper that Delhi-based Mankind is gathering funds to potentially finance the acquisition independently, though it may partner with another investor to avoid straining its balance sheet. The funds will also support organic growth.

Also Read | Union Budget 2024 likely to be tabled in Parliament by third week of July

Mankind is the fourth largest drug manufacturer in India by sales. It plans to raise up to 7,500 crore through a qualified institutional placement (QIP) and has increased its borrowing limit to 12,500 crore. In a recent earnings call discussing FY24 results, and a postal ballot notice for shareholder approval, the company indicated it is preparing for potential acquisitions, both large and small. It referred to reports of interest in Bharat Serums as speculative.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.MoreLess
First Published:13 Jun 2024, 02:20 PM IST
HomeCompaniesNewsMankind Pharma in talks with PE for consortium bid of Bharat Serums: Report

Most Active Stocks

Adani Power

728.00
02:18 PM | 9 JUL 2024
30.05 (4.31%)

Indian Oil Corporation

170.95
02:18 PM | 9 JUL 2024
0.8 (0.47%)

Bharat Electronics

332.80
02:18 PM | 9 JUL 2024
-1.35 (-0.4%)

GAIL India

229.25
02:18 PM | 9 JUL 2024
-1.25 (-0.54%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Welspun Living

164.00
02:05 PM | 9 JUL 2024
11.65 (7.65%)

Caplin Point Laboratories

1,527.00
02:06 PM | 9 JUL 2024
106.65 (7.51%)

KRBL

332.00
02:06 PM | 9 JUL 2024
23.2 (7.51%)

Blue Star

1,770.20
02:05 PM | 9 JUL 2024
114.8 (6.93%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K
    Bangalore
    73,983.00-110.00
    Chennai
    74,128.00-691.00
    Delhi
    74,346.00-473.00
    Kolkata
    75,074.00400.00

    Fuel Price

    • Petrol
    • Diesel
    Bangalore
    102.86/L0.00
    Chennai
    100.75/L0.00
    Kolkata
    104.95/L0.00
    New Delhi
    94.72/L0.00
    OPEN IN APP
    HomeMarketsCibilPremiumMint Shorts